Damora Therapeutics, Inc.
DMRA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001800315
In the last 90 days, Damora Therapeutics, Inc. insiders filed 1 open-market purchase and 1 sale; 104 institutions reported holding it in 13F filings for Q2 2026, worth $1.67B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q3 2025
Institutional positions in Damora Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- +3 vs. Q2 2025
- Shares held
- 170.2K
- +37.4K (+28.2%) vs. Q2 2025
- Total value
- $633.3K
- +$181.8K (+40.3%) vs. Q2 2025
- New holders
- 4
- 3 more added
- Sold out
- 1
- 3 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DMRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 104 | $1.67B |
| Q1 2026 | 65 | $1.45B |
| Q4 2025 | 18 | $65.5M |
| Q3 2025 | 12 | $633.3K |
| Q2 2025 | 9 | $451.5K |
| Q1 2025 | 11 | $442.4K |
| Q4 2024 | 10 | $660.7K |
| Q3 2024 | 10 | $1.56M |
| Q2 2024 | 22 | $1.91M |
| Q1 2024 | 26 | $3.09M |
| Q4 2023 | 22 | $2.77M |
| Q3 2023 | 22 | $3.92M |
| Q2 2023 | 27 | $25.7M |
| Q1 2023 | 26 | $17.8M |
| Q4 2022 | 22 | $10.2M |
| Q3 2022 | 26 | $17.3M |
| Q2 2022 | 23 | $15.7M |
| Q1 2022 | 25 | $21.0M |
| Q4 2021 | 26 | $30.5M |
| Q3 2021 | 25 | $37.2M |
| Q2 2021 | 27 | $57.4M |
| Q1 2021 | 19 | $82.9M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Damora Therapeutics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SBI Securities Co., Ltd. | 18 | $67 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 43 | $160 | 0.00% | +43 | New |
| Barclays PLC | 55 | $205 | 0.00% | −45−45.0% | Reduced |
| UBS Group AG | 59 | $220 | 0.00% | −2,254−97.4% | Reduced |
| BlackRock, Inc. | 100 | $372 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,427 | $5.31K | 0.00% | +485+51.5% | Added |
| Bank of America Corp | 6,500 | $24.2K | 0.00% | +5,272+429.3% | Added |
| Virtu Financial LLC | 13,128 | $49.0K | 0.00% | +13,128 | New |
| Renaissance Technologies LLC | 15,044 | $56.0K | 0.00% | +500+3.4% | Added |
| Two Sigma Investments, LP | 20,296 | $75.5K | 0.00% | +20,296 | New |
| Connective Capital Management, LLC | 26,956 | $100.3K | 0.09% | +26,956 | New |
| Novo Holdings A/S | 86,579 | $322.1K | 0.02% | −13,334−13.3% | Reduced |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −13,602−100.0% | Sold out |